We propose that VEGFR-1 downstream signaling regulates several pathways associated with cardiac hypertrophy and the balance of phosphorylation and activity of PKCα and mTOR could inhibit the initial development of compensatory LVH but eventually result in cardiomyocyte hypertrophy at a later time point. This evidence concerns the gene FLT1 and cardiac hypertrophy.